This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05792657
Recruitment Status : Recruiting
First Posted : March 31, 2023
Last Update Posted : March 31, 2023
Sponsor:
Collaborators:
Kristiania University College
ABEL Technologies
Information provided by (Responsible Party):
Norges idrettshøgskole

Brief Summary:
The ambition of the ABEL feasibility study is to test new "green prescription" follow-up models that can get more women with obesity, regularly active, with improved health and physical fitness. The project will evaluate the effect on exercise behavior, total physical activity level and mental and physical health outcomes by four different follow-up models by an exercise professional: HIGH-dosage in-person exercise coaching (four session monthly), MEDIUM- dosage in-person exercise coaching (two sessions monthly) LOW-dosage in-person exercise coaching (one session monthly). The main aim of this study is to evaluate which of these follow-up models is most effective on improving women's exercise adherence, total physical activity level, physical fitness, and mental and physical health. This will be weighed against the cost of each of the follow-up models, in order to identify the best model from a socioeconomic cost-effectiveness perspective. Moreover, the study will identify potential barriers among patients, General Practitioners and exercise professionals that prevents optimal outcome from the current green prescription model.

Condition or disease Intervention/treatment Phase
Obesity Behavioral: High dosage in-person exercise coaching Behavioral: Medium dosage in-person exercise coaching. Behavioral: Low dosage in-person exercise coaching Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Masking Description: Each participant will be randomly assigned (1:1:1:1) to one intervention group, HIGH, MEDIUM, LOW or CONTROL following a simple computer-based randomization program. All participants included in the study will conduct the baseline assessments before the randomization procedure. The study design will not allow for further masking of study participants or the exercise professional (caregivers to the interventions). Those from the research group involved in inclusion of the participants or follow-up measurements will not have access to the group allocation list. Further, all measurements will be completed and plotted without the research group information of group allocation. The statistical analyses will be done in SPSS, following a predefined analysis plan and before unmasking the study arms.
Primary Purpose: Prevention
Official Title: The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction): A Randomized Controlled Trial
Actual Study Start Date : January 26, 2023
Estimated Primary Completion Date : June 26, 2023
Estimated Study Completion Date : June 26, 2023

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: HIGH dosage in-person exercise coaching
One in-person exercise session with an exercise professional/weekly. A total of 20 hours of in-person coaching during the 20 weeks of intervention.
Behavioral: High dosage in-person exercise coaching
High dosage (one hour each week) of in-person exercise coaching by an exercise professional.

Experimental: MEDIUM dosage in-person exercise coaching
Two in-person exercise session with an exercise professional/monthly, and 15 minutes web-based behavioral support on the non-supervised weeks.A total of 10 hours in-person coaching during the 20 weeks intervention.
Behavioral: Medium dosage in-person exercise coaching.
Medium dosage (one hour every other week) of in-person exercise coaching by an exercise professional.

Experimental: LOW dosage in-person exercise coaching
One in-person exercise session with the exercise professional/monthly, and 15 minutes web-based behavioral support on the non-supervised weeks.Total of five hours of in-person coaching during the 20 weeks intervention.
Behavioral: Low dosage in-person exercise coaching
Low dosage (one hour every month) of in-person exercise coaching by an exercise professional

No Intervention: CONTROL
Will be asked to continuing with normal life, and will receive regular follow-up care from their GP. This group will be giving the "Norwegian Directorate of Health's" recommendations for physical activity and nutrition, and will have access to the ABEL-app in order to register physical activity and exercise, but will not be provided any coaching during the 20 weeks.



Primary Outcome Measures :
  1. Adherence (attendance) to prescribed exercise sessions [ Time Frame: Continuously during the intervention period of 20 weeks ]
    Measures of adherence to exercise sessions will be collected through the ABEL-app (ABEL Technologies). Sessions performed with the exercise professional will be logged through the ABEL-app of the exercise professional, while sessions performed independently will be logged through the ABEL-app of the participant. Participants adherence will be measured by attendance (percentage of exercise sessions completed out of exercise sessions offered).


Secondary Outcome Measures :
  1. Fulfillment of physical activity recommendations [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    To determine whether participants are meeting the physical activity recommendations, a single question whil be asked : "for the last six months, have you participated in more or less than 150 minutes of moderate physical activity each week?" Participants can respond either "more" or "less", where more is greater than less. Fulfillment of physical activity recommendations, exercise frequency, duration of exercise sessions and physical activity mode will be combined in order to measure participants physical activity behavior.

  2. Exercise frequency [ Time Frame: At baseline and following the intervention (20 weeks). ]
    Exercise frequency will be measured by a single questions: "how often do you exercise each week?" participants can give a respond from 0-"7, where 7 is greater than 0. Exercise frequency, fulfillment of physical activity recommendations, duration of exercise sessions and mode of physical activity will be combined in order to measure participants physical activity behavior.

  3. Duration of exercise sessions [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Duration of exercise sessions will be measured by a single question: "how long do you usually exercise per session? Participants can give a respond in minutes from "below 30 minutes" to "above 90 minutes", where above 90 minutes is greater than 30 minutes. Duration of exercise sessions, fulfillment of physical activity recommendations, mode of physical activity and frequency of exercise sessions will be combined in order to measure participants physical activity behavior.

  4. Mode of physical activity [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    To determine which type of physical activity participants performs, participants will answer a single question: "Which of the following types of activities do you usually participate in? Participants are able to select more than one response of: "Commuting activities", "activities at home", "cycling", "walking", "exercising at a fitness club", "home exercises", and "exercising in sports". Mode of physical activity, fulfillment of physical activity recommendations, exercise frequency and exercise durations will be combined to measure participants physical activity behavior.

  5. Health-related quality of life [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be measured by a Norwegian version of "The MOS 36-item short-form health survey" (SF-36). The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0-100. Lower scores = more disability, higher scores = less disability.

  6. Self-efficacy [ Time Frame: at baseline and following the intervention period (20 weeks) ]
    Will be measured by a Norwegian abbreviated validated version of a "Self-Efficacy Survey" consisting of 12 statements. The subscale covers four to eight statements where the participants rated each statement on a five-point scale, where 5 is the highest grade of self-efficacy, and 1 is the lowest. For each subscale, a sum score (from 1 to 5) will be calculated by adding scores from each statement, divided by the number of statements.

  7. Motivation for exercise and physical activity [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be measured by a Norwegian version of the validated survey "BREQ-2", which measures the levels of self-determination in motivation for exercise and physical activity on a 5-point Likert-scale (from 1 to 5). Score range from 0-100, where high scores means more intrinsic motivated for exercise and physical activity.

  8. Perceived social support from family and friends [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Questions to measure social support for exercise and physical activity will be based on a validated social support questionnaire consisting of 13 statements concerning social support from friends and family. The participants rate each statement on how often, on a five-point scale, their family or friends have been supportive of them exercising. A total social support score will be calculated (from 6 to 30), where higher scores demonstrated greater social support for exercise and physical activity.

  9. Stage of motivational readiness for exercise and physical activity [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be measured in line with a previously conducted questionnaire on exercise professionals effect on changing attitude towards physical activity and exercise. Participants will rate one statement (on how likely they are to start exercising the next six months) according to the five stages in the stages of change model: re-contemplation (not intending to make changes), Contemplation (considering a change), Preparation (getting ready to make a change), Action (actively engaged in making a change but only for a short while) & Maintenance (sustaining the change over time). "Maintenance" is the highest grade of motivation, followed by "Action", "Preparation" and "Contemplation". "Re-contemplation" is the lowest grade of motivation.

  10. Barriers to exercise [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Questions will be based on barriers previously identified among a Norwegian adult population (n= 12 504) and among fitness club members. 18 barriers will be included in the questionary. The participants rated how limiting they perceived each barrier to be on a three-point scale (1= not correct, 3=very correct). By adding the score from each barrier divided by the number of statements, a sum-score (from 1 to 3) for each subscale will be calculated.

  11. Urinary incontinence [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be measured using a Norwegian version of the "Incontinence Questionaire-Short Form (ICIQ-UI SF)". Measures will be given by a Likert scale from "never" to "all the time". Awareness and knowledge about pelvis floor muscles exercises will be assessed by single questions: "Do you do pelvic floor muscle exercises?" If yes, how many times weekly?" "If yes, has your exercise professional provided you any coaching on pelvic floor muscle exercises?"

  12. Glycated hemoglobin [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be collected through capillary blood drawn from finger pricks by Tigeni self testing kits. Measures will be given in mmol/L

  13. Blood pressure [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be assessed by the participants GP. Both systolic and diastolic blood pressure will be measured. Unit of measures is millimeters of mercury (mmHg).

  14. Weight [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be measured by the participants GP. Unit of measures is in kilogram (kg). Weight and height will be combined to report BMI in kg/m2

  15. Height [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be measured by the participants GP. Unit of measures is centimeters (cm). Weight and height will be combined to report BMI in kg/m2

  16. Cholesterol [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Cholesterol will be collected through capillary blood drawn from finger pricks by Tigeni self testing kits. Unit of measures is mmol/L

  17. Heart rate recovery [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Unit of measures is beats per minute (BPM). Heart rate recovery combined with RPE and working heart rate will be used to assess relative changes in participants aerobic endurance.

  18. The Borg Rating of Perceived Exertion (RPE) [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Measures will be given on a rating scale from 6 (no exertion) to 20 (maximal exertion). Participants will perform a standardized incline treadmill-walking test. RPE, heart rate recovery and changes in working heart rate will be combined to assess participants relative changes in aerobic endurance.

  19. Working heart rate [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Unit of measures is beats per minute (BPM). Working heart rate is combined with RPE and Heart rate recovery to assess participants relative changes in aerobic endurance.

  20. Muscular strength [ Time Frame: At baseline and following the intervention period (20 weeks) ]
    Will be assessed by a 1-RM (repetition maximum) estimation test in: chest press, close grip lat pull down and leg press. Load will progressively be increase until the participant reaches nine or less repetitions. Brzycki 1-RM prediction equation will be used to estimate the 1-RM based on the resistance and repetitions performed. The equation is mathematically expressed as 1RM = W/ [102.78- 2.78(R)]/100, where W is the weight used and R is the maximal number of repetitions performed.

  21. Factors associated with exercise adherence and drop-out [ Time Frame: Following the intervention period (20 weeks) ]
    n=15 of participants from the intervention group: HIGH, MEDIUM and LOW will be invited to participate in a semi-structured in-depth interview. A former investigation in Norway, including 14 questions designed to address factors associated with exercise adherence and drop-out. These questions will be combined with questions covering BPNES in order to measure participant's experiences, barriers and facilitators of participating in the study.

  22. Basic physicological needs in exercise (BPNES) [ Time Frame: Following the intervention period (20 weeks) ]
    n=15 of participants from the intervention group: HIGH, MEDIUM and LOW. Will be invited to participate in a semi-structured in-depth interview including questions covering fulfillment of BPNES (autonomy, relatedness and competence). Questions regarding fulfilment of BPNES will be combined with questions designed to address factors associated with exercise adherence and drop-out, to evaluate participant's experiences, barriers and facilitators of participating in the study.

  23. In-depth interview (general practitioners) [ Time Frame: Following the intervention period (20 weeks) ]
    n=8 general practitioners will participate in a semi-structured in-depth interview (approximately 45 min). The interview will be led by researchers from the project group, audiotaped and transcribed verbatim. Questions will be based on a previous qualitative study conducted on GPs in Norway, covering GPs experiences with the current green prescription model, and views on exercise as medicine.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age between 18 to 65 years
  • No fitness club membership six months prior to recruitment
  • Low-active (<150 minutes of moderate-intensity or 75 minutes of vigorous-intensity per week)
  • Norwegian speaking
  • In possession of a mobile phone.

Exclusion Criteria:

  • Chronic disease or pathology (e.g severe hypertension 180/110 mm Hg), heart disease or lung disease hindering exercise
  • Changing GP during the intervention
  • Functional impairment due to injuries hindering physical activity and exercise.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05792657


Contacts
Layout table for location contacts
Contact: Tron Krosshaug, PhD +4745660046 Tronk@nih.no
Contact: Elene M Tangen, Msc +4795787210 Elene.tangen@gmail.com

Locations
Layout table for location information
Norway
Norwegian School of Sport Sciences Recruiting
Oslo, Norway, 0806
Contact: Tron Krosshaug, PhD    +47 23 26 23 49    tronk@nih.no   
Sponsors and Collaborators
Norges idrettshøgskole
Kristiania University College
ABEL Technologies
Investigators
Layout table for investigator information
Study Chair: Tron Krosshaug, PhD Norwegian School of Sport Sciences
  Study Documents (Full-Text)

Documents provided by Norges idrettshøgskole:
Study Protocol  [PDF] March 19, 2023

Publications:
Brzycki M. Strength testing-predicting a one-rep max from reps-to-fatigue. Journal of Physical Education, Recreation & Dance. 1993;64(1):88-90.

Layout table for additonal information
Responsible Party: Norges idrettshøgskole
ClinicalTrials.gov Identifier: NCT05792657    
Other Study ID Numbers: EMT2023
First Posted: March 31, 2023    Key Record Dates
Last Update Posted: March 31, 2023
Last Verified: February 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Norges idrettshøgskole:
Exercise is medicine
Exercise adherence
Total physical activity level
Exercise professionals
Women with obesity (>30 BMI)
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Overweight
Overnutrition
Nutrition Disorders
Body Weight